Kathryn T. Hall, PhD Brigham and Women's Hospital, Harvard Medical School

Dr. Hall is an associate molecular biologist and assistant professor in the division of preventive medicine at Brigham and Women’s Hospital and director of placebo genetics in the Program in Placebo Studies at Harvard Medical School (HMS). After receiving her PhD in microbiology and molecular genetics from Harvard University she spent 10 years in the biotech industry tackling problems in drug discovery and development, first at Wyeth (now Pfizer) and then at Millennium Pharmaceuticals (now Takeda), where she became an associate director of drug development. Dr. Hall returned to HMS in 2010, joining the fellowship in integrative medicine at Beth Israel Deaconess Medical Center in 2012, and receiving a master’s in public health from Harvard T.H. Chan School of Public Health in 2014.


Do We Still Need Placebo Studies?

Assistant Professor
Boston, MA